BNRNasdaqServices-Medical Laboratories
Burning Rock Biotech Ltd
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026
$12.29−0.61 (-4.73%)
Close on Oct 19, 2026
Debt
Borrowings on the balance sheet, Dec 31, 2025
Total debt
CN¥1.70M
Long-term debt
Net debt
-CN¥476.69M
After CN¥478.39M of cash
Implied interest rate
–
FY2025 interest ÷ average debt
Interest coverage
–
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, CNY
Bond issues
Individual notes and bonds outstanding
Bond-level data is not connected yet
Coupon, maturity and amount of each note will come from the debt footnote in Burning Rock Biotech's annual report. Trading prices and yields need FINRA TRACE data.